Claudio Rapezzi

37.5k total citations · 7 hit papers
366 papers, 15.4k citations indexed

About

Claudio Rapezzi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Claudio Rapezzi has authored 366 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Cardiology and Cardiovascular Medicine, 128 papers in Molecular Biology and 63 papers in Surgery. Recurrent topics in Claudio Rapezzi's work include Amyloidosis: Diagnosis, Treatment, Outcomes (113 papers), Cardiomyopathy and Myosin Studies (77 papers) and Cardiovascular Function and Risk Factors (62 papers). Claudio Rapezzi is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (113 papers), Cardiomyopathy and Myosin Studies (77 papers) and Cardiovascular Function and Risk Factors (62 papers). Claudio Rapezzi collaborates with scholars based in Italy, United States and United Kingdom. Claudio Rapezzi's co-authors include Perry Elliott, Elena Biagini, Angelo Branzi, Lorenzo Monserrat, William J. McKenna, Maria Letizia Bacchi Reggiani, Fabrizio Salvi, Ornella Leone, Candida Cristina Quarta and Luigi Tavazzi and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Claudio Rapezzi

360 papers receiving 15.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

2007 1.9k citations Claudio Rapezzi, Petar Seferović et al. European Heart Journal profile →
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

2013 737 citations Claudio Rapezzi, Elena Biagini et al. European Heart Journal profile →
Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy

2005 607 citations Ornella Leone, Maria Letizia Bacchi Reggiani et al. profile →
Guideline of transthyretin-related hereditary amyloidosis for clinicians

2013 493 citations Laura Obici, Claudio Rapezzi et al. profile →
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis

2019 331 citations Thibaud Damy, Sharmila Dorbala et al. profile →
Long-Term Safety of Drug-Eluting and Bare-Metal Stents

2015 326 citations Maria Letizia Bacchi Reggiani, Claudio Rapezzi et al. profile →
RNA-targeting and gene editing therapies for transthyretin amyloidosis

2022 120 citations Alberto Aimo, Vincenzo Castiglione et al. profile →

Peers

Countries citing papers authored by Claudio Rapezzi

Since Specialization

Citations

This map shows the geographic impact of Claudio Rapezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Rapezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Rapezzi more than expected).

Fields of papers citing papers by Claudio Rapezzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Rapezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Rapezzi. The network helps show where Claudio Rapezzi may publish in the future.

Co-authorship network of co-authors of Claudio Rapezzi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Rapezzi. A scholar is included among the top collaborators of Claudio Rapezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Rapezzi. Claudio Rapezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) 2023 ·Global Heart ·Dulce Brito, (unknown), Diego Pérez de Arenaza, N. Bart, (unknown), (unknown), Isabel Conceição, Thibaud Damy, Sharmila Dorbala, (unknown), Pablo García‐Pavía, Junbo Ge, Julian D. Gillmore, Jacek Grzybowski, Laura Obici, (unknown), Claudio Rapezzi, Mitsuharu Ueda, Fausto J. Pinto	33
2	La morte improvvisa giovanile e in età adulta: cause e concause. L’esperienza della rete multidisciplinare in Emilia-Romagna 2022 ·Giornale italiano di cardiologia ·Ornella Leone, Valentina Agostini, Maddalena Graziosi, Cesare Rossi, Guido Pelletti, Alberto Foà, (unknown), Mattia Riefolo, Matteo Ziacchi, Paolo Fais, Susi Pelotti, Claudio Rapezzi, Marco Seri	4
3	Restrictive cardiomyopathy: definition and diagnosis 2022 ·European Heart Journal ·Claudio Rapezzi, Alberto Aimo, Andrea Barison, Michele Emdin, Aldostefano Porcari, Aleš Linhart, Andre Keren, Marco Merlo, Gianfranco Sinagra	90
4	Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments 2022 ·European Heart Journal ·Iacopo Olivotto, James E. Udelson, Maurizio Pieroni, Claudio Rapezzi	20
5	Amiloidosi cardiaca. Come si diagnostica, come si cura – di Michele Emdin, Giuseppe Vergaro, Claudio Passino 2022 ·Giornale italiano di cardiologia ·Claudio Rapezzi	1
6	EXPLORER-HCM: il mavacamten nel trattamento della cardiomiopatia ipertrofica ostruttiva sintomatica 2021 ·Giornale italiano di cardiologia ·Claudio Rapezzi	1
7	99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis 2021 ·European Heart Journal - Cardiovascular Imaging ·Candida Cristina Quarta, (unknown), David F. Hutt, (unknown), Richa Manwani, Sajitha Sachchithanantham, Shameem Mahmood, Carol Whelan, Marianna Fontana, Ana Martinez–Naharro, Liza Chacko, Helen J. Lachmann, Julian D. Gillmore, Claudio Rapezzi, Philip N. Hawkins, Ashutosh Wechalekar	42
8	Mutations in MYBPC3 and MYH7 in Association with Brugada Type 1 ECG Pattern: Overlap between Brugada Syndrome and Hypertrophic Cardiomyopathy? 2021 ·SHILAP Revista de lepidopterología ·(unknown), Cristina Balla, (unknown), Rita Selvatici, (unknown), (unknown), Paola Imbrici, Elia De Maria, Mauro Biffi, Matteo Bertini, Claudio Rapezzi, Alessandra Ferlini, Francesca Gualandi	5
9	Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis 2021 ·Journal of the American Heart Association ·Angela Pucci, Alberto Aimo, Veronica Musetti, Andrea Barison, Giuseppe Vergaro, Dario Genovesi, Assuero Giorgetti, Silvia Masotti, Chiara Arzilli, Concetta Prontera, Luigi Emilio Pastormerlo, Michele Coceani, Marco Ciardetti, Nicola Martini, Cataldo Palmieri, Claudio Passino, Claudio Rapezzi, Michele Emdin	69
10	Treatment of cardiac transthyretin amyloidosis: an update 2019 ·European Heart Journal ·Michele Emdin, Alberto Aimo, Claudio Rapezzi, Marianna Fontana, Federico Perfetto, Petar Seferović, Andrea Barison, Vincenzo Castiglione, Giuseppe Vergaro, Alberto Giannoni, Claudio Passino, Giampaolo Merlini	111
11	Il cardiologo e le mucopolisaccaridosi. Raccomandazioni del GICEM (Gruppo Italiano Cardiologi Esperti Malattie Metaboliche) su diagnosi, follow-up e management cardiologico 2017 ·Giornale italiano di cardiologia ·Pierluigi Russo, Generoso Andria, (unknown), (unknown), (unknown), Roberto Della Casa, Andrea Imperatori, Giovanni Battista Luciani, (unknown), Rossella Parini, Maurizio Pieroni, Maria Antonia Prioli, Luca Ragni, Claudio Rapezzi, Gabriele Rinelli, Marta Rubino, Cristiano Sarais, P Sciacca, Francesco Seddio, Giuseppe Limongelli	5
12	Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 2017 ·Journal of Interventional Cardiology ·Gianni Dall’Ara, Antonío Marzocchi, Nevio Taglieri, Carolina Moretti, (unknown), (unknown), (unknown), Cinzia Marrozzini, (unknown), (unknown), Claudio Rapezzi, Francesco Saia	6
13	Acute Heart Failure in Patients with Acute Aortic Syndrome: Pathophysiology and Clinical–Prognostic Implications 2015 ·European Journal of Heart Failure ·(unknown), Anna Corsini, Massimiliano Lorenzini, Davide Pacini, Marinella Ferlito, Maria Letizia Bacchi Reggiani, Simone Longhi, (unknown), (unknown), (unknown), Giulia Bugani, Ferdinando Pasquale, Elena Biagini, Francesco Grigioni, Roberto Di Bartolomeo, Marco Marini, Gian Piero Perna, Giovanni Melandri, Claudio Rapezzi	9
14	Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment. 2015 ·PubMed ·Barbara Bordoni, Carolina Moretti, Cinzia Marrozzini, Cristina Ciuca, Gianni Dall’Ara, (unknown), (unknown), Nevio Taglieri, Alessandra Berardini, Paolo Guastaroba, Maria Letizia Bacchi Reggiani, Claudio Rapezzi, Antonío Marzocchi, Francesco Saia	8
15	La cardiomiopatia amiloidotica correlata alla transtiretina: alla ricerca del trattamento eziologico 2014 ·Giornale italiano di cardiologia ·Simone Longhi, Christian Gagliardi, Agnese Milandri, Lisa Manuzzi, Claudio Rapezzi	2
16	Cambi di paradigma in tema di aorta: implicazioni cliniche e terapeutiche La biopatologia dell’aorta 2013 ·Giornale italiano di cardiologia ·Giulia d’Amati, Ornella Leone, Stefano Nistri, Alberto Roghi, Annalisa Angelini, Cristina Basso, Elena Biagini, (unknown), Donato Mele, Guglielmina Pepe, Claudio Rapezzi, Gaetano Thiene	2
17	Sempre oscura mi fu quest’aVR. L’insospettabile ricchezza di una derivazione dimenticata 2012 ·Giornale italiano di cardiologia ·Gabriele Bronzetti, (unknown), Claudio Rapezzi	3
18	Dronedarone: una reale innovazione o solo una valida seconda scelta? Come districarsi tra linee guida, agenzie regolatorie e pratica clinica quotidiana 2012 ·Giornale italiano di cardiologia ·Alessandro Capucci, Federico Guerra, (unknown), Roberto Antonicelli, (unknown), Giuseppe Boriani, (unknown), N Ciampani, (unknown), Domenico Gabrielli, Marcello Galvani, Massimo Margheri, Francesco Melandri, Maria Grazia Modena, Gian Piero Perna, (unknown), Giancarlo Piovaccari, (unknown), Claudio Rapezzi, Giovanni Villani	1
19	“Effetto donna” nelle cardiomiopatie 2012 ·Giornale italiano di cardiologia ·Elena Biagini, Alessandra Berardini, Maddalena Graziosi, Stefania Rosmini, (unknown), Claudio Rapezzi	2
20	Primary endoleakage in endovascular treatment of the thoracic aorta: Importance of intraoperative transesophageal echocardiography 2000 ·Journal of Thoracic and Cardiovascular Surgery ·Rossella Fattori, Ilaria Caldarera, Claudio Rapezzi, Guido Rocchi, G. Napoli, (unknown), (unknown), Angelo Pierangeli, Giampaolo Gavelli	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact